A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein called amyloid-β was responsible for memory loss in Alzheimer’s disease. On its ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...

Beta-amyloid plaques are considered a hallmark of Alzheimer’s disease, but they’re not the sole cause of the disease and its symptoms. Alzheimer’s is a complicated disease that experts are still ...

Share on Pinterest Are anti-amyloid drugs as effective against Alzheimer’s disease as experts had hoped? Image credit: smodj/Getty Images More than 55 million people worldwide are living with ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Getting your steps in could help fight off Alzheimer's, new research ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by binding to and removing beta-amyloid plaques through various mechanisms, ...

Findings show lower amyloid PET positivity in Black and Latinx adults with cognitive impairment, highlighting disparities in ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In an unprecedented large-scale study, researchers have mapped out the ...